Skip to main content
. 2016 Dec 10;8(4):6341–6352. doi: 10.18632/oncotarget.13856

Figure 4. The cytotoxic activity (as concentration vs survival measured by FMCA) and mean IC50 (95% confidence intervals) of cytarabine, daunorubicin, melflufen and melphalan in AML patient samples.

Figure 4

Error bars denote SEM.